“The Trump Justice Department, following a tougher policy toward dubious False Claims Act lawsuits by private citizens, has moved to dismiss a pair of lawsuits by a former hedge-fund manager who shorted stock in pharmaceutical companies he accused of a wide-ranging price-fixing conspiracy.” [Daniel Fisher, Legal NewsLine/Forbes]

Filed under: pharmaceuticals, qui tam, whistleblowers